Literature DB >> 10756163

Immunostimulatory activity of the bacterial extract OM-8.

M Huber1, M Ayoub, S D Pfannes, K Mittenbühler, K Weis, W G Bessler, W Baier.   

Abstract

The bacterial extract OM-89 used for the prevention and treatment of recurrent urinary tract infections constitutes an effective immunostimulant in vitro and in vivo. Here we demonstrate that OM-89 shows mitogenic properties towards murine spleen cell cultures from LPS responder and non-responder mice. In macrophages the extract induces the translocation of NF-kappaB into the cell nucleus and RNI (radical nitrogen intermediates) release, which could be attributed to single fractions of the extract. Our findings on the in vitro immunostimulatory effect of OM-89, as well as its immunogenic and adjuvant properties, are of importance for understanding its therapeutic efficacy as demonstrated in clinical studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10756163

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  3 in total

Review 1.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

Review 2.  Alternative Therapeutic Options to Antibiotics for the Treatment of Urinary Tract Infections.

Authors:  Paul Loubet; Jérémy Ranfaing; Aurélien Dinh; Catherine Dunyach-Remy; Louis Bernard; Franck Bruyère; Jean-Philippe Lavigne; Albert Sotto
Journal:  Front Microbiol       Date:  2020-07-03       Impact factor: 5.640

3.  Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study.

Authors:  Derick Wade; James Cooper; Fadel Derry; Julian Taylor
Journal:  Trials       Date:  2019-04-16       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.